|
|
|
|
|
|  PerkinElmer Life Sciences supplies products, services and technologies for functional genomics, high throughput screening and drug discovery as well as for clinical screening. Customers throughout the world are involved in a broad range of research efforts connected with the treatment and cure of disease. Such efforts range from discovering specific genes and understanding their function, to identifying the biological targets for new drugs as well as screening for new drug candidates. Clinical screening programs carried out by our customers also serve to alleviate or prevent disease by identifying those members of the population most at risk later in their lives. PerkinElme is a critical partner to both scientists and clinicians who are working to improve human health.
Products supplied comprise instrumentation, software and consumables, including reagents. The products are based on a core expertise in fluorescent, chemiluminescent and radioactive labelling and detection of nucleic acids and proteins. PerkinElmer proprietary technologies include time-resolved fluorescence which is employed in the sensitive Wallac DELFIA® system and Wallac LANCE™ homogeneous assay system, and fluorescence polarisation, [FP]2™, a robust fluorescence-based technique for receptor binding assays that is both fast and easy-to-use.
Dalej
|
|
|
|
Phadia
